| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_297a93bcdbddfc8254fa6772886c9a37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4390594574717a9f0fdd78cb7f1277f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76ba102ea9c02b6633d64bf09c5b89a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_935e9af6d2fbffa5e72442dbf0e3b191
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b59e01aed400063ed5e702e5e957cf98 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-022 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0058
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2013-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5a0a13577acf52913efaecc69ace64a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19f94522925b7cbd519795e31b1b2262
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ceb0ab46b61ba7d2ed06986e71c01aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4db01f124968419d6bf20d20c56665aa |
| publicationDate |
2013-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013266610-A1 |
| titleOfInvention |
Stimulating anti-tumor immune response and boosting cancer immunotherapy via expression of 15-pgdh |
| abstract |
Disclosed herein are methods and materials for inhibiting tumor growth by administering viral vectors to tumor cells. Particularly exemplified herein are methods of inhibiting tumor growth of colon tumors by delivering 15-PGDH to tumor environment. Antigen presenting cells may be coadministered with 15-PGDH. |
| priorityDate |
2008-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |